Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors

Figure 2

The analysis of overall survival (OS) between different groups. (a) Absolute monocyte count (AMC); (b) lactate dehydrogenase (LDH); (c) platelet-lymphocyte ratio (PLR); (d) different treatment regimens; (e) absolute count of CD8⁺CD28⁻ T cells.

(a)

(b)

(c)

(d)

(e)